Fairfield, Bush & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.15M Buy
2,187
+30
+1% +$15.8K 0.65% 43
2025
Q1
$1.37M Buy
2,157
+193
+10% +$122K 0.87% 36
2024
Q4
$1.4M Buy
1,964
+125
+7% +$89K 0.82% 37
2024
Q3
$1.93M Sell
1,839
-137
-7% -$144K 1.15% 27
2024
Q2
$2.08M Sell
1,976
-6
-0.3% -$6.31K 1.24% 24
2024
Q1
$1.91M Sell
1,982
-76
-4% -$73.2K 1.13% 26
2023
Q4
$1.81M Buy
2,058
+123
+6% +$108K 1.06% 27
2023
Q3
$1.59M Buy
1,935
+115
+6% +$94.7K 1.04% 28
2023
Q2
$1.31M Buy
1,820
+95
+6% +$68.3K 0.36% 60
2023
Q1
$1.42M Sell
1,725
-245
-12% -$201K 0.5% 50
2022
Q4
$1.42M Buy
1,970
+171
+10% +$123K 0.94% 28
2022
Q3
$1.24M Buy
1,799
+155
+9% +$107K 0.87% 31
2022
Q2
$972K Sell
1,644
-170
-9% -$101K 0.57% 42
2022
Q1
$1.27M Sell
1,814
-637
-26% -$445K 0.64% 40
2021
Q4
$1.55M Sell
2,451
-50
-2% -$31.6K 0.74% 35
2021
Q3
$1.51M Sell
2,501
-245
-9% -$148K 0.49% 53
2021
Q2
$1.53M Buy
2,746
+1,292
+89% +$722K 0.42% 52
2021
Q1
$688K Buy
1,454
+565
+64% +$267K 0.2% 96
2020
Q4
$429K Sell
889
-496
-36% -$239K 0.13% 113
2020
Q3
$775K Buy
1,385
+805
+139% +$450K 0.25% 80
2020
Q2
$362K Buy
+580
New +$362K 0.13% 102
2017
Q4
Sell
-500
Closed -$224K 160
2017
Q3
$224K Hold
500
0.07% 137
2017
Q2
$246K Buy
+500
New +$246K 0.08% 130
2016
Q4
Sell
-500
Closed -$201K 151
2016
Q3
$201K Buy
+500
New +$201K 0.07% 144
2016
Q1
Sell
-500
Closed -$271K 139
2015
Q4
$271K Hold
500
0.09% 120
2015
Q3
$233K Hold
500
0.1% 116
2015
Q2
$255K Hold
500
0.08% 147
2015
Q1
$226K Hold
500
0.07% 160
2014
Q4
$205K Buy
+500
New +$205K 0.06% 168